Financial reports
10-Q
2023 Q3
Quarterly report
9 Nov 23
10-Q
2023 Q2
Quarterly report
9 Aug 23
10-Q
2023 Q1
Quarterly report
11 May 23
ARS
2022 FY
Annual report to shareholders
25 Apr 23
10-K
2022 FY
Annual report
30 Mar 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
13 May 22
10-K
2021 FY
Annual report
28 Mar 22
10-Q
2021 Q3
Quarterly report
22 Nov 21
Current reports
8-K
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
21 Mar 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
15 Mar 24
8-K
Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq
14 Mar 24
8-K
Regulation FD Disclosure
11 Mar 24
8-K
Regulation FD Disclosure
4 Mar 24
8-K
Better Therapeutics and Glooko Announce Partnership to Accelerate Adoption of AspyreRx to Treat Type 2 Diabetes in the United States
8 Jan 24
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
15 Dec 23
8-K
Entry into a Material Definitive Agreement
13 Dec 23
8-K
Entry into a Material Definitive Agreement
30 Nov 23
8-K
Departure of Directors or Certain Officers
20 Nov 23
Registration and prospectus
424B3
Prospectus supplement
21 Mar 24
424B3
Prospectus supplement
15 Mar 24
424B3
Prospectus supplement
14 Mar 24
RW
Registration withdrawal request
1 Mar 24
S-1/A
IPO registration (amended)
6 Feb 24
D
$250.00 k in equity, sold $250.00 k, 1 investor
23 Jan 24
424B3
Prospectus supplement
10 Jan 24
424B3
Prospectus supplement
28 Dec 23
S-1/A
IPO registration (amended)
26 Dec 23
S-1/A
IPO registration (amended)
21 Dec 23
Proxies
Other
EFFECT
Notice of effectiveness
28 Dec 23
CORRESP
Correspondence with SEC
26 Dec 23
CORRESP
Correspondence with SEC
22 Dec 23
CORRESP
Correspondence with SEC
21 Dec 23
UPLOAD
Letter from SEC
21 Dec 23
EFFECT
Notice of effectiveness
17 Oct 23
CORRESP
Correspondence with SEC
12 Oct 23
UPLOAD
Letter from SEC
22 Aug 23
EFFECT
Notice of effectiveness
26 Apr 23
EFFECT
Notice of effectiveness
26 Apr 23
Ownership
4
DAVID P PERRY
13 Feb 24
SC 13G/A
MMCAP International Inc. SPC
13 Feb 24
SC 13D/A
David P. Perry 2015 Trust
12 Feb 24
SC 13D/A
David P. Perry 2015 Trust
25 Jan 24
4
DAVID P PERRY
10 Jan 24
4
DAVID P PERRY
20 Dec 23
4
Richard H Carmona
20 Dec 23
4
RISA J LAVIZZO-MOUREY
20 Dec 23
4
Kristin Wynholds
20 Dec 23
4
Geoffrey M. Parker
20 Dec 23